Φορτώνει......
Inactivation of yellow fever virus with amotosalen and ultraviolet A light pathogen‐reduction technology
BACKGROUND: The reemergence of yellow fever virus (YFV) in Africa and Brazil, and massive vaccine campaigns triggered to contain the outbreaks, have raised concerns over blood transfusion safety and availability with increased risk of YFV transfusion‐transmitted infections (TTIs) by native and vacci...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Transfusion |
|---|---|
| Κύριοι συγγραφείς: | , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
John Wiley & Sons, Inc.
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7078960/ https://ncbi.nlm.nih.gov/pubmed/31957887 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/trf.15673 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|